World Alzheimer’s Month: How MultiPark research contributes to understanding, diagnosing and treating Alzheimer’s disease
New biomarkers can make Alzheimer’s disease easier to detect and diagnoses more accurate, which may be crucial as disease-modifying treatments are available. And the diagnostic toolbox could expand even further, predicts one of MultiPark’s newest research group leaders, who is working on an AI model designed to detect several different conditions linked to dementia from a single blood test. But Mu
